EMEA-002024-PIP01-16

Key facts

Active substance
  • hydrochlorothiazide
  • Candesartan cilexetil
  • Amlodipine besilate
Therapeutic area
Cardiovascular diseases
Decision number
P/0037/2017
PIP number
EMEA-002024-PIP01-16
Pharmaceutical form(s)
Tablet
Condition(s) / indication(s)
Treatment of hypertension
Route(s) of administration
Oral use
Contact for public enquiries
Midas Pharma GmbH
Germany
Tel. +49 61329900
E-mail: ra@midas-pharma.com
Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

How useful was this page?

Add your rating